The First Biosimilar reached the US market… and it’s from Novartis
Biosimilar or copies of biological drugs are arriving on the market. After Europe, US gets…
September 8, 2015 - 2 minutes
Cancer: Keep up to Date with the Latest in Oncology
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
Show More
Editor's Picks for Cancer
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Immuno-Oncology: From Science Fiction to the Mainstream
- ADC Approval Buoys Spirits in Cancer Treatment Space
- Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
- Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest Cancer Articles
Wasp venom kills Cancer cells
Side effects of cancer treatments are almost as feared as the disease itself. But what…
September 8, 2015 - 2 minutes
A Slice of Europe: MD Anderson looks to invest in EU Immuno-Oncology
MD Anderson is expanding its Immatics sharehold to spawn new Houston-based subsidiary Immatics US through…
September 7, 2015 - 3 minutes
CAR-T therapy first clinical proof: Patient lives cancer-free 5 years on
A pioneering CAR-T cell therapy study from Novartis and the University of Pennsylvania demonstrates the…
September 4, 2015 - 4 minutes
Adaptimmune Clinical Trials full-steam ahead with GSK investment!
Adaptimmune has had exciting results regarding the ongoing battle with Synovial Sarcoma. GSK looks to…
September 3, 2015 - 3 minutes
Review: The Future of Biomarkers in Immuno-Oncology
Immuno-oncology is a Biotech field that is more than just hype - it could solve…
August 31, 2015 - 5 minutes
Dutch Immuno-Oncology company raises Massive Series C Financing round
Sofinnova Ventures and Novo A/S step into one of the biggest European series C financing…
August 27, 2015 - 2 minutes
Dutch Startup receives €2.5M from Europe to Block Cancer’s Spreading
The Eurostars program supports the Dutch start-up Oncodrone with fresh money to bring its metastasis-blocking…
August 27, 2015 - 2 minutes
Leading German Biotechs MorphoSys and Immatics partner to pump up their Immuno-Oncology Therapies
Two German biotechs with highly successful platforms join forces to fight cancer. MorphoSys and Immatics…
August 25, 2015 - 2 minutes
New mAb-treatment Improves the Life of European Children with Neuroblastoma
The European Commission granted marketing authorisation for United Therapeutics' Unituxin for the treatment of neuroblastoma in…
August 18, 2015 - 2 minutes
Not only Genes matter, Cellular Origin determines the Cancer Type
Cancer occurs in uncountable forms, and we are far away from understanding all the mechanisms…
August 18, 2015 - 2 minutes
Roche abandons Wilex to Make Way for Immuno-Oncology
Roche just dropped a first-generation antibody-based treatment preventing cancer cells from proliferating. Interestingly enough, the…
August 13, 2015 - 3 minutes
